| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |